ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.
Identifieur interne : 003430 ( PubMed/Corpus ); précédent : 003429; suivant : 003431ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.
Auteurs : F. Cardoso ; A. Costa ; L. Norton ; E. Senkus ; M. Aapro ; F. André ; C H Barrios ; J. Bergh ; L. Biganzoli ; K L Blackwell ; M J Cardoso ; T. Cufer ; N. El Saghir ; L. Fallowfield ; D. Fenech ; P. Francis ; K. Gelmon ; S H Giordano ; J. Gligorov ; A. Goldhirsch ; N. Harbeck ; N. Houssami ; C. Hudis ; B. Kaufman ; I. Krop ; S. Kyriakides ; U N Lin ; M. Mayer ; S D Merjaver ; E B Nordström ; O. Pagani ; A. Partridge ; F. Penault-Llorca ; M J Piccart ; H. Rugo ; G. Sledge ; C. Thomssen ; L. Van'T Veer ; D. Vorobiof ; C. Vrieling ; N. West ; B. Xu ; E. WinerSource :
- Annals of oncology : official journal of the European Society for Medical Oncology [ 1569-8041 ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- classification : Breast Neoplasms.
- drug therapy : Breast Neoplasms.
- pathology : Breast Neoplasms.
- surgery : Breast Neoplasms.
- Female, Guidelines as Topic, Humans, Neoplasm Grading, Treatment Outcome.
DOI: 10.1093/annonc/mdu385
PubMed: 25234545
Links to Exploration step
pubmed:25234545Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.</title><author><name sortKey="Cardoso, F" sort="Cardoso, F" uniqKey="Cardoso F" first="F" last="Cardoso">F. Cardoso</name><affiliation><nlm:affiliation>European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal fatimacardoso@fundacaochampalimaud.pt.</nlm:affiliation></affiliation></author><author><name sortKey="Costa, A" sort="Costa, A" uniqKey="Costa A" first="A" last="Costa">A. Costa</name><affiliation><nlm:affiliation>European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Norton, L" sort="Norton, L" uniqKey="Norton L" first="L" last="Norton">L. Norton</name><affiliation><nlm:affiliation>Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Senkus, E" sort="Senkus, E" uniqKey="Senkus E" first="E" last="Senkus">E. Senkus</name><affiliation><nlm:affiliation>Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.</nlm:affiliation></affiliation></author><author><name sortKey="Aapro, M" sort="Aapro, M" uniqKey="Aapro M" first="M" last="Aapro">M. Aapro</name><affiliation><nlm:affiliation>Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Andre, F" sort="Andre, F" uniqKey="Andre F" first="F" last="André">F. André</name><affiliation><nlm:affiliation>Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France.</nlm:affiliation></affiliation></author><author><name sortKey="Barrios, C H" sort="Barrios, C H" uniqKey="Barrios C" first="C H" last="Barrios">C H Barrios</name><affiliation><nlm:affiliation>Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Bergh, J" sort="Bergh, J" uniqKey="Bergh J" first="J" last="Bergh">J. Bergh</name><affiliation><nlm:affiliation>Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Biganzoli, L" sort="Biganzoli, L" uniqKey="Biganzoli L" first="L" last="Biganzoli">L. Biganzoli</name><affiliation><nlm:affiliation>Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Blackwell, K L" sort="Blackwell, K L" uniqKey="Blackwell K" first="K L" last="Blackwell">K L Blackwell</name><affiliation><nlm:affiliation>Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Cardoso, M J" sort="Cardoso, M J" uniqKey="Cardoso M" first="M J" last="Cardoso">M J Cardoso</name><affiliation><nlm:affiliation>Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal.</nlm:affiliation></affiliation></author><author><name sortKey="Cufer, T" sort="Cufer, T" uniqKey="Cufer T" first="T" last="Cufer">T. Cufer</name><affiliation><nlm:affiliation>University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia.</nlm:affiliation></affiliation></author><author><name sortKey="El Saghir, N" sort="El Saghir, N" uniqKey="El Saghir N" first="N" last="El Saghir">N. El Saghir</name><affiliation><nlm:affiliation>NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.</nlm:affiliation></affiliation></author><author><name sortKey="Fallowfield, L" sort="Fallowfield, L" uniqKey="Fallowfield L" first="L" last="Fallowfield">L. Fallowfield</name><affiliation><nlm:affiliation>Brighton & Sussex Medical School, University of Sussex, Falmer, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Fenech, D" sort="Fenech, D" uniqKey="Fenech D" first="D" last="Fenech">D. Fenech</name><affiliation><nlm:affiliation>Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.</nlm:affiliation></affiliation></author><author><name sortKey="Francis, P" sort="Francis, P" uniqKey="Francis P" first="P" last="Francis">P. Francis</name><affiliation><nlm:affiliation>Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Gelmon, K" sort="Gelmon, K" uniqKey="Gelmon K" first="K" last="Gelmon">K. Gelmon</name><affiliation><nlm:affiliation>BC Cancer Agency, Vancouver, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Giordano, S H" sort="Giordano, S H" uniqKey="Giordano S" first="S H" last="Giordano">S H Giordano</name><affiliation><nlm:affiliation>Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gligorov, J" sort="Gligorov, J" uniqKey="Gligorov J" first="J" last="Gligorov">J. Gligorov</name><affiliation><nlm:affiliation>APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Goldhirsch, A" sort="Goldhirsch, A" uniqKey="Goldhirsch A" first="A" last="Goldhirsch">A. Goldhirsch</name><affiliation><nlm:affiliation>Program of Breast Health, European Institute of Oncology, Milan, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Harbeck, N" sort="Harbeck, N" uniqKey="Harbeck N" first="N" last="Harbeck">N. Harbeck</name><affiliation><nlm:affiliation>Brustzentrum der Universität München, Munich, Denmark.</nlm:affiliation></affiliation></author><author><name sortKey="Houssami, N" sort="Houssami, N" uniqKey="Houssami N" first="N" last="Houssami">N. Houssami</name><affiliation><nlm:affiliation>Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Hudis, C" sort="Hudis, C" uniqKey="Hudis C" first="C" last="Hudis">C. Hudis</name><affiliation><nlm:affiliation>Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kaufman, B" sort="Kaufman, B" uniqKey="Kaufman B" first="B" last="Kaufman">B. Kaufman</name><affiliation><nlm:affiliation>Sheba Medical Center, Tel Hashomer, Israel.</nlm:affiliation></affiliation></author><author><name sortKey="Krop, I" sort="Krop, I" uniqKey="Krop I" first="I" last="Krop">I. Krop</name><affiliation><nlm:affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kyriakides, S" sort="Kyriakides, S" uniqKey="Kyriakides S" first="S" last="Kyriakides">S. Kyriakides</name><affiliation><nlm:affiliation>Europa Donna Cyprus, Nicosa, Cyprus.</nlm:affiliation></affiliation></author><author><name sortKey="Lin, U N" sort="Lin, U N" uniqKey="Lin U" first="U N" last="Lin">U N Lin</name><affiliation><nlm:affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Mayer, M" sort="Mayer, M" uniqKey="Mayer M" first="M" last="Mayer">M. Mayer</name><affiliation><nlm:affiliation>AdvancedBC.org, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Merjaver, S D" sort="Merjaver, S D" uniqKey="Merjaver S" first="S D" last="Merjaver">S D Merjaver</name><affiliation><nlm:affiliation>University of Michigan Medical School and School of Public Health, Ann Arbor, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Nordstrom, E B" sort="Nordstrom, E B" uniqKey="Nordstrom E" first="E B" last="Nordström">E B Nordström</name><affiliation><nlm:affiliation>Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Pagani, O" sort="Pagani, O" uniqKey="Pagani O" first="O" last="Pagani">O. Pagani</name><affiliation><nlm:affiliation>Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Partridge, A" sort="Partridge, A" uniqKey="Partridge A" first="A" last="Partridge">A. Partridge</name><affiliation><nlm:affiliation>Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Penault Llorca, F" sort="Penault Llorca, F" uniqKey="Penault Llorca F" first="F" last="Penault-Llorca">F. Penault-Llorca</name><affiliation><nlm:affiliation>Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.</nlm:affiliation></affiliation></author><author><name sortKey="Piccart, M J" sort="Piccart, M J" uniqKey="Piccart M" first="M J" last="Piccart">M J Piccart</name><affiliation><nlm:affiliation>Department of Medicine, Institut Jules Bordet, Brussels, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Rugo, H" sort="Rugo, H" uniqKey="Rugo H" first="H" last="Rugo">H. Rugo</name><affiliation><nlm:affiliation>Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco.</nlm:affiliation></affiliation></author><author><name sortKey="Sledge, G" sort="Sledge, G" uniqKey="Sledge G" first="G" last="Sledge">G. Sledge</name><affiliation><nlm:affiliation>Indiana University Medical CTR, Indianapolis, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Thomssen, C" sort="Thomssen, C" uniqKey="Thomssen C" first="C" last="Thomssen">C. Thomssen</name><affiliation><nlm:affiliation>Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Van T Veer, L" sort="Van T Veer, L" uniqKey="Van T Veer L" first="L" last="Van'T Veer">L. Van'T Veer</name><affiliation><nlm:affiliation>Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Vorobiof, D" sort="Vorobiof, D" uniqKey="Vorobiof D" first="D" last="Vorobiof">D. Vorobiof</name><affiliation><nlm:affiliation>Sandton Oncology Centre, Johannesburg, South Africa.</nlm:affiliation></affiliation></author><author><name sortKey="Vrieling, C" sort="Vrieling, C" uniqKey="Vrieling C" first="C" last="Vrieling">C. Vrieling</name><affiliation><nlm:affiliation>Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="West, N" sort="West, N" uniqKey="West N" first="N" last="West">N. West</name><affiliation><nlm:affiliation>Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Xu, B" sort="Xu, B" uniqKey="Xu B" first="B" last="Xu">B. Xu</name><affiliation><nlm:affiliation>Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Winer, E" sort="Winer, E" uniqKey="Winer E" first="E" last="Winer">E. Winer</name><affiliation><nlm:affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25234545</idno><idno type="pmid">25234545</idno><idno type="doi">10.1093/annonc/mdu385</idno><idno type="wicri:Area/PubMed/Corpus">003430</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003430</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.</title><author><name sortKey="Cardoso, F" sort="Cardoso, F" uniqKey="Cardoso F" first="F" last="Cardoso">F. Cardoso</name><affiliation><nlm:affiliation>European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal fatimacardoso@fundacaochampalimaud.pt.</nlm:affiliation></affiliation></author><author><name sortKey="Costa, A" sort="Costa, A" uniqKey="Costa A" first="A" last="Costa">A. Costa</name><affiliation><nlm:affiliation>European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Norton, L" sort="Norton, L" uniqKey="Norton L" first="L" last="Norton">L. Norton</name><affiliation><nlm:affiliation>Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Senkus, E" sort="Senkus, E" uniqKey="Senkus E" first="E" last="Senkus">E. Senkus</name><affiliation><nlm:affiliation>Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.</nlm:affiliation></affiliation></author><author><name sortKey="Aapro, M" sort="Aapro, M" uniqKey="Aapro M" first="M" last="Aapro">M. Aapro</name><affiliation><nlm:affiliation>Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Andre, F" sort="Andre, F" uniqKey="Andre F" first="F" last="André">F. André</name><affiliation><nlm:affiliation>Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France.</nlm:affiliation></affiliation></author><author><name sortKey="Barrios, C H" sort="Barrios, C H" uniqKey="Barrios C" first="C H" last="Barrios">C H Barrios</name><affiliation><nlm:affiliation>Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Bergh, J" sort="Bergh, J" uniqKey="Bergh J" first="J" last="Bergh">J. Bergh</name><affiliation><nlm:affiliation>Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Biganzoli, L" sort="Biganzoli, L" uniqKey="Biganzoli L" first="L" last="Biganzoli">L. Biganzoli</name><affiliation><nlm:affiliation>Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Blackwell, K L" sort="Blackwell, K L" uniqKey="Blackwell K" first="K L" last="Blackwell">K L Blackwell</name><affiliation><nlm:affiliation>Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Cardoso, M J" sort="Cardoso, M J" uniqKey="Cardoso M" first="M J" last="Cardoso">M J Cardoso</name><affiliation><nlm:affiliation>Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal.</nlm:affiliation></affiliation></author><author><name sortKey="Cufer, T" sort="Cufer, T" uniqKey="Cufer T" first="T" last="Cufer">T. Cufer</name><affiliation><nlm:affiliation>University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia.</nlm:affiliation></affiliation></author><author><name sortKey="El Saghir, N" sort="El Saghir, N" uniqKey="El Saghir N" first="N" last="El Saghir">N. El Saghir</name><affiliation><nlm:affiliation>NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.</nlm:affiliation></affiliation></author><author><name sortKey="Fallowfield, L" sort="Fallowfield, L" uniqKey="Fallowfield L" first="L" last="Fallowfield">L. Fallowfield</name><affiliation><nlm:affiliation>Brighton & Sussex Medical School, University of Sussex, Falmer, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Fenech, D" sort="Fenech, D" uniqKey="Fenech D" first="D" last="Fenech">D. Fenech</name><affiliation><nlm:affiliation>Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.</nlm:affiliation></affiliation></author><author><name sortKey="Francis, P" sort="Francis, P" uniqKey="Francis P" first="P" last="Francis">P. Francis</name><affiliation><nlm:affiliation>Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Gelmon, K" sort="Gelmon, K" uniqKey="Gelmon K" first="K" last="Gelmon">K. Gelmon</name><affiliation><nlm:affiliation>BC Cancer Agency, Vancouver, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Giordano, S H" sort="Giordano, S H" uniqKey="Giordano S" first="S H" last="Giordano">S H Giordano</name><affiliation><nlm:affiliation>Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gligorov, J" sort="Gligorov, J" uniqKey="Gligorov J" first="J" last="Gligorov">J. Gligorov</name><affiliation><nlm:affiliation>APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Goldhirsch, A" sort="Goldhirsch, A" uniqKey="Goldhirsch A" first="A" last="Goldhirsch">A. Goldhirsch</name><affiliation><nlm:affiliation>Program of Breast Health, European Institute of Oncology, Milan, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Harbeck, N" sort="Harbeck, N" uniqKey="Harbeck N" first="N" last="Harbeck">N. Harbeck</name><affiliation><nlm:affiliation>Brustzentrum der Universität München, Munich, Denmark.</nlm:affiliation></affiliation></author><author><name sortKey="Houssami, N" sort="Houssami, N" uniqKey="Houssami N" first="N" last="Houssami">N. Houssami</name><affiliation><nlm:affiliation>Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Hudis, C" sort="Hudis, C" uniqKey="Hudis C" first="C" last="Hudis">C. Hudis</name><affiliation><nlm:affiliation>Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kaufman, B" sort="Kaufman, B" uniqKey="Kaufman B" first="B" last="Kaufman">B. Kaufman</name><affiliation><nlm:affiliation>Sheba Medical Center, Tel Hashomer, Israel.</nlm:affiliation></affiliation></author><author><name sortKey="Krop, I" sort="Krop, I" uniqKey="Krop I" first="I" last="Krop">I. Krop</name><affiliation><nlm:affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kyriakides, S" sort="Kyriakides, S" uniqKey="Kyriakides S" first="S" last="Kyriakides">S. Kyriakides</name><affiliation><nlm:affiliation>Europa Donna Cyprus, Nicosa, Cyprus.</nlm:affiliation></affiliation></author><author><name sortKey="Lin, U N" sort="Lin, U N" uniqKey="Lin U" first="U N" last="Lin">U N Lin</name><affiliation><nlm:affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Mayer, M" sort="Mayer, M" uniqKey="Mayer M" first="M" last="Mayer">M. Mayer</name><affiliation><nlm:affiliation>AdvancedBC.org, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Merjaver, S D" sort="Merjaver, S D" uniqKey="Merjaver S" first="S D" last="Merjaver">S D Merjaver</name><affiliation><nlm:affiliation>University of Michigan Medical School and School of Public Health, Ann Arbor, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Nordstrom, E B" sort="Nordstrom, E B" uniqKey="Nordstrom E" first="E B" last="Nordström">E B Nordström</name><affiliation><nlm:affiliation>Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Pagani, O" sort="Pagani, O" uniqKey="Pagani O" first="O" last="Pagani">O. Pagani</name><affiliation><nlm:affiliation>Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Partridge, A" sort="Partridge, A" uniqKey="Partridge A" first="A" last="Partridge">A. Partridge</name><affiliation><nlm:affiliation>Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Penault Llorca, F" sort="Penault Llorca, F" uniqKey="Penault Llorca F" first="F" last="Penault-Llorca">F. Penault-Llorca</name><affiliation><nlm:affiliation>Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.</nlm:affiliation></affiliation></author><author><name sortKey="Piccart, M J" sort="Piccart, M J" uniqKey="Piccart M" first="M J" last="Piccart">M J Piccart</name><affiliation><nlm:affiliation>Department of Medicine, Institut Jules Bordet, Brussels, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Rugo, H" sort="Rugo, H" uniqKey="Rugo H" first="H" last="Rugo">H. Rugo</name><affiliation><nlm:affiliation>Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco.</nlm:affiliation></affiliation></author><author><name sortKey="Sledge, G" sort="Sledge, G" uniqKey="Sledge G" first="G" last="Sledge">G. Sledge</name><affiliation><nlm:affiliation>Indiana University Medical CTR, Indianapolis, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Thomssen, C" sort="Thomssen, C" uniqKey="Thomssen C" first="C" last="Thomssen">C. Thomssen</name><affiliation><nlm:affiliation>Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Van T Veer, L" sort="Van T Veer, L" uniqKey="Van T Veer L" first="L" last="Van'T Veer">L. Van'T Veer</name><affiliation><nlm:affiliation>Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Vorobiof, D" sort="Vorobiof, D" uniqKey="Vorobiof D" first="D" last="Vorobiof">D. Vorobiof</name><affiliation><nlm:affiliation>Sandton Oncology Centre, Johannesburg, South Africa.</nlm:affiliation></affiliation></author><author><name sortKey="Vrieling, C" sort="Vrieling, C" uniqKey="Vrieling C" first="C" last="Vrieling">C. Vrieling</name><affiliation><nlm:affiliation>Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="West, N" sort="West, N" uniqKey="West N" first="N" last="West">N. West</name><affiliation><nlm:affiliation>Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Xu, B" sort="Xu, B" uniqKey="Xu B" first="B" last="Xu">B. Xu</name><affiliation><nlm:affiliation>Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Winer, E" sort="Winer, E" uniqKey="Winer E" first="E" last="Winer">E. Winer</name><affiliation><nlm:affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Annals of oncology : official journal of the European Society for Medical Oncology</title><idno type="eISSN">1569-8041</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (classification)</term><term>Breast Neoplasms (drug therapy)</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (surgery)</term><term>Female</term><term>Guidelines as Topic</term><term>Humans</term><term>Neoplasm Grading</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Guidelines as Topic</term><term>Humans</term><term>Neoplasm Grading</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25234545</PMID><DateCreated><Year>2014</Year><Month>09</Month><Day>27</Day></DateCreated><DateCompleted><Year>2015</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1569-8041</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>10</Issue><PubDate><Year>2014</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Annals of oncology : official journal of the European Society for Medical Oncology</Title><ISOAbbreviation>Ann. Oncol.</ISOAbbreviation></Journal><ArticleTitle>ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.</ArticleTitle><Pagination><MedlinePgn>1871-88</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/annonc/mdu385</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal fatimacardoso@fundacaochampalimaud.pt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norton</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senkus</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aapro</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>André</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrios</LastName><ForeName>C H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergh</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biganzoli</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blackwell</LastName><ForeName>K L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cufer</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Saghir</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fallowfield</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Brighton & Sussex Medical School, University of Sussex, Falmer, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fenech</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francis</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelmon</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>BC Cancer Agency, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>S H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gligorov</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldhirsch</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Program of Breast Health, European Institute of Oncology, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harbeck</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Brustzentrum der Universität München, Munich, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houssami</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hudis</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaufman</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Sheba Medical Center, Tel Hashomer, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krop</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kyriakides</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Europa Donna Cyprus, Nicosa, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>U N</ForeName><Initials>UN</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>AdvancedBC.org, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merjaver</LastName><ForeName>S D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>University of Michigan Medical School and School of Public Health, Ann Arbor, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nordström</LastName><ForeName>E B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagani</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Partridge</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penault-Llorca</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piccart</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Institut Jules Bordet, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rugo</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sledge</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Indiana University Medical CTR, Indianapolis, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomssen</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van't Veer</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vorobiof</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sandton Oncology Centre, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vrieling</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winer</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Oncol</MedlineTA><NlmUniqueID>9007735</NlmUniqueID><ISSNLinking>0923-7534</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2000 Nov 15;18(22):3748-57</RefSource><PMID Version="1">11078487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Feb;119(3):537-45</RefSource><PMID Version="1">19876731</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Nurs. 2010 Mar-Apr;33(2):127-40</RefSource><PMID Version="1">20142736</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2011 Dec 1;29(34):4498-504</RefSource><PMID Version="1">22025143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2011 Apr;20(2):145-50</RefSource><PMID Version="1">20870406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2008 Nov-Dec;14(6):562-9</RefSource><PMID Version="1">19000052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Jun 20;25(18):2522-7</RefSource><PMID Version="1">17577029</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Feb 1;23(4):792-9</RefSource><PMID Version="1">15681523</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 May 10;30(14):1594-600</RefSource><PMID Version="1">22393084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Ther. 2013 Oct;30(10):870-84</RefSource><PMID Version="1">24158787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 1974 Mar;38(3):476-9</RefSource><PMID Version="1">4815174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2011;11:197</RefSource><PMID Version="1">21609498</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2012 Feb 9;366(6):520-9</RefSource><PMID Version="1">22149876</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2011 Jan 20;29(3):264-71</RefSource><PMID Version="1">21149659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2012 Nov 8;367(19):1783-91</RefSource><PMID Version="1">23020162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2012 Apr;13(4):e148-60</RefSource><PMID Version="1">22469125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Radiat Oncol. 1997 Oct;7(4):260-266</RefSource><PMID Version="1">10717223</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2001 Sep;12(9):1247-54</RefSource><PMID Version="1">11697835</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Clin Oncol. 2003 Jun;26(3):317-22</RefSource><PMID Version="1">12796608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Oncol Pract. 2009 Jul;5(4):150-2</RefSource><PMID Version="1">20856626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2005 Jul 15;104(2):236-9</RefSource><PMID Version="1">15937908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2014 Jun;15(7):747-56</RefSource><PMID Version="1">24794243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Educ. 2006 Spring;21(1 Suppl):S11-4</RefSource><PMID Version="1">17020496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):998-1004</RefSource><PMID Version="1">19560883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):39-45</RefSource><PMID Version="1">22330986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Dec;136(3):777-88</RefSource><PMID Version="1">23104222</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2011 Mar 12;377(9769):914-23</RefSource><PMID Version="1">21376385</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2003 Sep;14(9):1391-8</RefSource><PMID Version="1">12954578</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2007 Feb;16(1):9-10</RefSource><PMID Version="1">17390420</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Oncol. 2013 Apr;20(2):111-7</RefSource><PMID Version="1">23559874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2004 Sep 15;22(18):3685-93</RefSource><PMID Version="1">15289491</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2001 Oct 1;92(7):1759-68</RefSource><PMID Version="1">11745247</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2014 Sep 1;32(25):2758-64</RefSource><PMID Version="1">25071111</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2012;17(7):891-9</RefSource><PMID Version="1">22584436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2013;12:CD008792</RefSource><PMID Version="1">24347031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2008 Dec;19(12):2012-9</RefSource><PMID Version="1">18641006</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Apr 1;26(10):1664-70</RefSource><PMID Version="1">18316794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2011 Mar;22(3):515-23</RefSource><PMID Version="1">20603440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2012 Dec;48(18):3355-77</RefSource><PMID Version="1">23116682</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2010 Jun;9(6):1775-87</RefSource><PMID Version="1">20530711</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Oct 20;26(30):4883-90</RefSource><PMID Version="1">18794551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2013 Sep;14(10):989-98</RefSource><PMID Version="1">23902874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2007;105 Suppl 1:33-43</RefSource><PMID Version="1">17912634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 Jan 20;28(3):375-9</RefSource><PMID Version="1">20008645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Surg Oncol. 2012 Jan;38(1):52-6</RefSource><PMID Version="1">22032912</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Nov;136(2):487-93</RefSource><PMID Version="1">23053638</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Apr 20;26(12):1980-6</RefSource><PMID Version="1">18421049</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2014 Apr;23(2):165-9</RefSource><PMID Version="1">24368024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2008 Dec 15;113(12):3391-9</RefSource><PMID Version="1">18951521</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2003 Jun 1;21(11):2101-9</RefSource><PMID Version="1">12775735</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2011 Nov;130(2):553-60</RefSource><PMID Version="1">21617918</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2003;8(6):521-30</RefSource><PMID Version="1">14657530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Pharmacol. 2013 Oct 5;717(1-3):71-83</RefSource><PMID Version="1">23545364</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1994 Mar 16;86(6):441-6</RefSource><PMID Version="1">7907149</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Aug 1;23(22):5108-16</RefSource><PMID Version="1">15998903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 2010 Dec;97(3):535-40</RefSource><PMID Version="1">21074876</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2009 Sep 2;101(17):1174-81</RefSource><PMID Version="1">19657108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2014 Feb;15(2):156-63</RefSource><PMID Version="1">24439313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2012 Jan 12;366(2):109-19</RefSource><PMID Version="1">22149875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1996 Jul 1;35(4):731-44</RefSource><PMID Version="1">8690639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2011 Nov-Dec;17(6):579-85</RefSource><PMID Version="1">21906206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2013 Oct;22(5):606-15</RefSource><PMID Version="1">24007941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Surg. 2012;12:5</RefSource><PMID Version="1">22469291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1997 Sep 1;80(5):886-91</RefSource><PMID Version="1">9307188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2010 Mar 11;362(10):865-9</RefSource><PMID Version="1">20220181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2014 Apr;144(2):223-32</RefSource><PMID Version="1">24557340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2012 Apr;21(2):112-23</RefSource><PMID Version="1">22094116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2000 Nov 15;18(22):3758-67</RefSource><PMID Version="1">11078488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chest. 2006 Jan;129(1):174-81</RefSource><PMID Version="1">16424429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2013 Dec;14(13):1317-25</RefSource><PMID Version="1">24239210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2011 Sep;129(2):459-65</RefSource><PMID Version="1">21713372</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2013 Oct;22(5):593-605</RefSource><PMID Version="1">24001709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1991 Jul;21(2):299-310</RefSource><PMID Version="1">2061107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 1999 Oct;5(10):2948-53</RefSource><PMID Version="1">10537364</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Jpn J Clin Oncol. 2012 Oct;42(10):970-3</RefSource><PMID Version="1">22833684</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2007 Sep 1;110(5):965-72</RefSource><PMID Version="1">17614302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Oncol. 2013;8:13</RefSource><PMID Version="1">23311297</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 2014 Mar;110(3):505-10</RefSource><PMID Version="1">24444530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 May;115(2):359-63</RefSource><PMID Version="1">18649131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2014 Dec;25(12):2357-62</RefSource><PMID Version="1">25231953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2012 Dec;29(5):3282-90</RefSource><PMID Version="1">22843291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2014 May 17;383(9930):1721-30</RefSource><PMID Version="1">24559581</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2006 May 15;106(10):2095-103</RefSource><PMID Version="1">16598749</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2001 Mar 15;344(11):783-92</RefSource><PMID Version="1">11248153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1999 Feb;17(2):485-93</RefSource><PMID Version="1">10080589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2014 Jun;23(3):209-20</RefSource><PMID Version="1">24767882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1994 Oct;12(10):2071-7</RefSource><PMID Version="1">7931476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2009 Oct;18(5):271-2</RefSource><PMID Version="1">19762241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 May 1;23(13):3079-85</RefSource><PMID Version="1">15860867</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Feb 10;26(5):786-90</RefSource><PMID Version="1">18258987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2014 Feb;144(1):153-62</RefSource><PMID Version="1">24504379</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2012 Apr;13(4):345-52</RefSource><PMID Version="1">22265697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2011 Sep;47 Suppl 3:S6-22</RefSource><PMID Version="1">21944030</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2012 Oct;38(6):708-14</RefSource><PMID Version="1">22178456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2012;14(4):R110</RefSource><PMID Version="1">22817698</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 Oct 20;28(30):4594-600</RefSource><PMID Version="1">20855825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Radiat Oncol. 2006 Jan;16(1):2-9</RefSource><PMID Version="1">16378901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2013 Jun;22(3):203-10</RefSource><PMID Version="1">23601761</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biol Ther. 2012 Jan 15;13(2):71-6</RefSource><PMID Version="1">22231391</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2011 Apr;20 Suppl 2:S3-11</RefSource><PMID Version="1">21392996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2012 Jun;21(3):242-52</RefSource><PMID Version="1">22425534</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2010 Jun;19(3):246-8</RefSource><PMID Version="1">20227277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2010 Mar 1;116(5):1226-33</RefSource><PMID Version="1">20101736</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1293-302</RefSource><PMID Version="1">11955742</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2012 Sep;23 Suppl 10:x349-53</RefSource><PMID Version="1">22987990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2009;(4):CD003370</RefSource><PMID Version="1">19821307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2015 Feb 20;33(6):594-601</RefSource><PMID Version="1">25605862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2011 Nov 10;29(32):4286-93</RefSource><PMID Version="1">21990397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2004 Aug 15;22(16):3302-8</RefSource><PMID Version="1">15310773</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 Aug 1;30(22):2718-24</RefSource><PMID Version="1">22565002</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2011 Jun 10;29(17):2342-9</RefSource><PMID Version="1">21555689</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2015 Jan 1;33(1):13-21</RefSource><PMID Version="1">25092775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Clin Pract Oncol. 2007 Feb;4(2):86-100</RefSource><PMID Version="1">17259930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2003 Jul 15;98(2):229-38</RefSource><PMID Version="1">12872340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Care. 2008 Aug;46(8):762-70</RefSource><PMID Version="1">18665055</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2011 Apr 1;29(10):1252-60</RefSource><PMID Version="1">21383283</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2010;12(6):R92</RefSource><PMID Version="1">21059212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2002 May 6;86(9):1367-72</RefSource><PMID Version="1">11986765</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017408" MajorTopicYN="Y">Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060787" MajorTopicYN="Y">Neoplasm Grading</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC4176456</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25234545</ArticleId><ArticleId IdType="pii">mdu385</ArticleId><ArticleId IdType="doi">10.1093/annonc/mdu385</ArticleId><ArticleId IdType="pmc">PMC4176456</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003430 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003430 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:25234545
|texte= ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:25234545" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |